The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
de Lissovoy G, Zenilman J, Nelson KE, Ahmed F, Celentano DD. The cost of a preventable disease: estimated U.S. national medical expenditures for congenital syphilis, 1990. Public Health Rep 1995;110:403-9.
Drug Topics Red Book. Montvale, NJ: Medical Economics Company, Inc., 1995.
Ebrahim SH, Peterman TA, Zaidi AA, Kamb ML. Mortality related to sexually transmitted diseases in women, U.S., 1973-1992. Eleventh Meeting of the International Society for STD Research, August 27-30, 1995, New Orleans, LA [abstract no. 343].
Fish RM. Herpes simplex. In: Fish RM, Campbell ET, Trupin SR, eds. Sexually transmitted diseases: problems in primary care. Los Angeles: Practice Management Information Corporation, 1992.
Grimes DA. Deaths due to sexually transmitted diseases: the forgotten component of reproductive mortality. JAMA 1986;255:1727-9.
Hall CB, Halsey NA. Control of hepatitis B: to be or not to be? Pediatrics 1992;90 [2 Pt. 1] 274-7.
Hellinger FJ. Forecasts of the costs of medical care for persons with HIV: 1992-1995. Inquiry 1992;29:356-65.
Hibbs JR, Gunn RA. Public health intervention in a cocaine-related syphilis outbreak. Am J Public Health 1991;81:1259-62.
IMS America. National disease and therapeutic index (NDTI). Plymouth Meeting, PA: IMS America, 1993.
IOM (Institute of Medicine). New vaccine development: establishing priorities; vol. I, Diseases of importance in the United States. Washington, D.C.: National Academy Press, 1985.
Johnson RE, Nahmias AJ, Magder LS, Lee FK, Broods CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States . N Engl J Med 1989;321:7-12.
Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991;11:84-92.
Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. JAMA 1995;274:1201-8.
Moran JS, Kaufman JA, Felsenstein D. Survey of health care providers: who sees patients needing STD services, and what services do they provide? Sex Transm Dis 1995;22:67-9.
NIH (National Institutes of Health). Disease-specific estimates of direct and indirect costs of illness and NIH support. Draft document, February 1995.
Oriel D. Genital human papillomavirus infection. In: Holmes KK, Mårdh P-A, Sparling PF, Wiesner PJ, Cates W Jr., Lemon SM, Stamm WE, eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990.
Paavonen J, Koutsky LA, Kiviat N. Cervical neoplasia and other STD-related genital and anal neoplasms. In: Holmes KK, Mårdh P-A, Sparling PF, Wiesner PJ, Cates W Jr., Lemon SM, et al., eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990.
Randolph AG, Washington AE, Prober CG. Cesarean delivery for women presenting with genital herpes lesions: efficacy, risks, and costs. JAMA 1993;270:77-82.
Reeves WC, Rawls WE, Brinton LA. Epidemiology of genital papillomaviruses and cervical cancer. Rev Infect Dis 1989;11:426-39.
Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: a replication and update. Health Care Financ Rev 1985;7:61-80.
Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
Schmid GP, Sanders LL, Blount JH, Alexander ER. Chancroid in the United States: re-establishment of an old disease. JAMA 1987;258:3265-8.